Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Micrima Limited logo — Redefining Cancer Diagnostics

Micrima Limited

Redefining Cancer Diagnostics

Founded 2005 United Kingdom Bristol, United Kingdom 26 employees Series D Total: $19.25M Biotechnology, Health Care +1

General Information

Company Name Micrima Limited
Founded Year 2005
Location United Kingdom Bristol, United Kingdom
Employees 26
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series D
Business Model D2C, B2B2C, B2B
Revenue Model Service Fee, Product Sales, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Micrima Limited. To contact Micrima Limited, visit micrima.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Micrima Limited compare?

A PDF of Micrima Limited and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Micrima Limited soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Micrima Limited

Micrima Limited, with its slogan "Redefining Cancer Diagnostics", was established in 2005 to innovate within the breast cancer diagnostic sector. The company is headquartered in the United Kingdom and operates in the fields of Biotechnology, Health Care, and Medical Devices.

Micrima's flagship innovation, the MARIA system, leverages microwave radar technology for breast imaging, significantly enhancing diagnostic accuracy. This technology was initially developed at the University of Bristol and is currently undergoing clinical trials, aimed at refining a machine learning algorithm for better diagnostic outcomes. The upcoming release in 2022 promises improved density information and enhanced ergonomics.

In terms of funding, Micrima's most recent financial boost was a £1.90M Series A investment received on 21 April 2021, with contributions from notable backers such as Angel CoFund and Technology Venture Partners. This investment is pivotal for advancing their clinical trials and market readiness in the burgeoning field of cancer diagnostics.

Business keywords: cancer diagnostics, microwave radar, breast imaging, MARIA system, clinical trials, machine learning algorithms, breast screening, density information, ergonomics, clinical research, university spin-off, data collection, innovative medical devices

Services & Products

Mi~Scan® breast density measurement
Mi~Score® personal health insights
In-person appointments for breast health

Target Customers

women concerned about breast health individuals with a family history of breast cancer health-conscious women women's health practitioners

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note £3.80M 5
Future Fund Technology Venture Partners ACF Investors
Future Fund, Technology Venture Partners +3
01 Apr 2021
Series D £4.40M 3
Technology Venture Partners VentureFounders ACF Investors
Technology Venture Partners, VentureFounders +1
01 Jun 2018
Series C €3.10M 4
Technology Venture Partners ACF Investors University of Bristol Enterprise Fund
Technology Venture Partners, ACF Investors +2
01 Sep 2016
Series B £2.60M 1
VentureFounders
VentureFounders
01 Apr 2016
Grant €250.00K -
01 Apr 2015
Early VC £600.00K 1
ACF Investors
ACF Investors
01 Sep 2012
Series A $4.00M 2
YFM Equity Partners Swarraton Partners
YFM Equity Partners, Swarraton Partners
01 Apr 2008
Seed £500.00K 1
Quester Capital
Quester Capital
01 Mar 2006
Spinout Undisclosed 1
University of Bristol Enterprise Fund
University of Bristol Enterprise Fund
01 Jan 2005

Micrima Limited Alternatives & Competitors

View All Alternatives
Micrima Limited vs
The Blue Box Biomedical Solutions
The Blue Box Biomedical Solutions Spain

Breast cancer prevention, as easy as a pregnancy test.

Seed
8 employees
AI, Health Care
Compare Micrima Limited vs The Blue Box Biomedical Solutions
Micrima Limited vs
Lunit Cancer Screening
Lunit Cancer Screening United States

Lunit is a public company that develops medical AI software that helps conquer cancer globally.

Post-IPO Debt
320 employees
AI, Analytics
Compare Micrima Limited vs Lunit Cancer Screening
Micrima Limited vs
Poltreg
Poltreg

Harnessing groundbreaking TREG therapy for global health innovation.

Grant
Biotechnology, Health Care
Also compare with: Micrima Limited vs BioAesthetics BioAesthetics Micrima Limited vs Atossa Therapeutics Atossa Therapeutics View all alternatives

FAQ About Micrima Limited

Redefining Cancer Diagnostics
Micrima Limited was founded in 2005.
Micrima Limited is headquartered in Bristol, United Kingdom.
Micrima Limited operates in Biotechnology, Health Care and Medical Devices. Its work centres on cancer diagnostics, microwave radar, breast imaging and MARIA system. Its customers include women concerned about breast health, individuals with a family history of breast cancer and health-conscious women.
Micrima Limited has a D2C, B2B2C and B2B business model. Its revenue comes from Service Fee, Product Sales and Usage Based.
Micrima Limited has approximately 26 employees.
Micrima Limited has completed 9 funding rounds, raising a total of $19.25M. The latest funding stage is Series D.
Micrima Limited offers: Mi~Scan® breast density measurement, Mi~Score® personal health insights, In-person appointments for breast health.
Top alternatives and competitors to Micrima Limited include The Blue Box Biomedical Solutions, Lunit Cancer Screening, Poltreg, BioAesthetics, Lily MedTech Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Micrima Limited and The Blue Box Biomedical Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Micrima Limited, https://bouncewatch.com/company/micrima-limited, updated 22 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout